Motivational Behavioral and Functional MRI Impairment in Patients With Chronic Neuropathic Pain
MOTION
1 other identifier
observational
50
1 country
1
Brief Summary
The main hypothesis of this study is that the alteration of the reward circuitry underlying the motivational deficit in chronic pain patients compared to healthy subjects results in a decrease in the capacity for reward learning. The fMRI studies have shown that this type of learning depends on the dopaminergic system innervating key regions of the reward system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2023
CompletedFirst Posted
Study publicly available on registry
January 27, 2023
CompletedStudy Start
First participant enrolled
December 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
January 5, 2026
December 1, 2025
3.4 years
January 10, 2023
December 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To compare reward learning ability in patients with chronic neuropathic pain compared with an age (±5 years) and gender-matched control population
the reward learning ability will be assessed using a specific task. The result of the task questionnaire is a numeric score.
Day 0
Study Arms (2)
cases : patients with chronic pain
controls
Interventions
during usual follow-up patients will complete a remard learning task questionnaire. This questionnaire cannot be assimilated to a clinical intervention.
Eligibility Criteria
The study will be proposed to patients followed at the pain treatment center or in neurosurgery for chronic neuropathic pain, of peripheral or central origin. Controls will be recruited among the patients' companions and the staff of the Adolphe de Rothschild Foundation Hospital.
You may qualify if:
- For cases: patients managed in the neurosurgery department or at CETD for chronic neuropathic pain, of central or peripheral origin.
- For controls: matched to a case on age (±5 years) and sex
You may not qualify if:
- Neurodegenerative or inflammatory neurological pathology
- Clinical depressive syndrome
- High doses of opioid treatment (greater than 100 mg/day of morphine equivalent)
- Impaired judgment or inability to receive information that does not allow the performance of behavioral tasks
- Absolute contraindication to MRI (e.g. pacemaker, implantable pacemaker, metallic intra-orbital foreign body)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Fondation Adolphe de Rothschild
Paris, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2023
First Posted
January 27, 2023
Study Start
December 19, 2023
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
January 5, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share